EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations

Jovanka R King iD, Kalle Grill, Lennart Hammarström

International Journal of Neonatal Screening · 11.04.2023 · 9 (2) · 22

DOI: 10.3390/ijns9020022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 11.04.2023. Verfasst von Jovanka R King und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy & Clinical Immunology, Women's and Children's Hospital Network, North Adelaide, SA 5006, Australia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inborn errors of immunity (IEI) are a group of over 450 genetically distinct conditions associated with significant morbidity and mortality, for which early diagnosis and treatment improve outcomes. Newborn screening for severe combined immunodeficiency (SCID) is currently underway in several countries, utilising a DNA-based technique to quantify T cell receptor excision circles (TREC) and kappa-deleting recombination excision circles (KREC). This strategy will only identify those infants with an IEI associated with T and/or B cell lymphopenia. Other severe forms of IEI will not be detected. Up-front, first-tier genomic-based newborn screening has been proposed as a potential approach by which to concurrently screen infants for hundreds of monogenic diseases at birth. Given the clinical, phenotypic and genetic heterogeneity of IEI, a next-generation sequencing-based newborn screening approach would be suitable. There are, however, several ethical, legal and social issues which must be evaluated in detail prior to adopting a genomic-based newborn screening approach, and these are discussed herein in the context of IEI.

Schlagwörter

Stichwörter der Autor:innen

ethical, legal and social considerations (ELSI)inborn errors of immunity (IEI)newborn screeningnext-generation sequencing (NGS)whole-exome sequencing (WES)whole-genome sequencing (WGS)

Autor:innen und Institutionen

  • Department of Allergy & Clinical Immunology, Women's and Children's Hospital Network, North Adelaide, SA 5006, Australia.
  • Immunology Directorate, SA Pathology, Adelaide, SA 5000, Australia.
  • Robinson Research Institute and Discipline of Paediatrics, School of Medicine, University of Adelaide, North Adelaide, SA 5006, Australia.
  • Department of Historical, Philosophical and Religious Studies, Umeå University, SE-90187 Umeå, Sweden.
  • Department of Biosciences and Nutrition, Neo, Karolinska Institutet, SE-14183 Huddinge, Sweden.

ORCID-Profile: Jovanka R King

Zitieren

APA

King, J. R., Grill, K., & Hammarström, L. (2023). Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations. International Journal of Neonatal Screening, 9(2), 22. https://doi.org/10.3390/ijns9020022

Vancouver

King JR, Grill K, Hammarström L. Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations. International Journal of Neonatal Screening. 2023;9(2):22. doi:10.3390/ijns9020022

BibTeX
@article{King2023,
  author = {King, Jovanka R and Grill, Kalle and Hammarström, Lennart},
  title = {Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations},
  journal = {International Journal of Neonatal Screening},
  year = {2023},
  volume = {9},
  number = {2},
  pages = {22},
  doi = {10.3390/ijns9020022}
}
Kostenlos starten →